Anúncio
Anúncio
ALZN
Alzamend Neuro, Inc. Common Stock
2.39
USDPatrocinado
+0.05
+2.18%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
2.35
-0.04
-1.88%
Relatórios de Lucros ALZN
Rácio de surpresa positiva
ALZN separação 8 de 16 últimas estimativas.
50%
Próximo Relatório
Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/-$2.10
Mudanças implicadas de Q2 26 (Revenue/ EPS)
--
/+600.00%
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/+22.81%
Alzamend Neuro, Inc. Common Stock earnings per share and revenue
On 09 de dez. de 2025, ALZN reported earnings of -0.30 USD per share (EPS) for Q2 26, beating the estimate of -1.99 USD, resulting in a 84.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -0.46% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 4 analistas forecast an EPS of -2.10 USD, with revenue projected to reach -- USD, implying an aumentar of 600.00% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Alzamend Neuro, Inc. Common Stock's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Alzamend Neuro, Inc. Common Stock reported EPS of -$0.30, beating estimates by 84.96%, and revenue of $0.00, 0% as expectations.
How did the market react to Alzamend Neuro, Inc. Common Stock's Q2 2026 earnings?
The stock price moved down -0.46%, changed from $2.17 before the earnings release to $2.16 the day after.
When is Alzamend Neuro, Inc. Common Stock expected to report next?
The next earning report is scheduled for 09 de mar. de 2026.
What are the forecasts for Alzamend Neuro, Inc. Common Stock's next earnings report?
Based on 4
analistas, Alzamend Neuro, Inc. Common Stock is expected to report EPS of -$2.10 and revenue of -- for Q3 2026.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio